Reflex Sympathetic Dystrophy Syndrome Association Rsdsa
Milford, Connecticut
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Good
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Filing History
13 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $824,669↑36% | $576,749↑5% | $1,931,743↑15% | — |
| 2022 | $606,080↓15% | $547,589↑18% | $1,672,832↓1% | — |
| 2021 | $712,313↑27% | $465,171↓38% | $1,684,715↑4% | — |
| 2020 | $562,434↓37% | $752,953↓17% | $1,623,582↑6% | — |
| 2019 | $890,427↑12% | $904,651↑29% | $1,536,890 | — |
| 2018 | $794,514↓15% | $703,003↑5% | $1,539,767↑7% | — |
| 2017 | $939,414↑27% | $668,359↑8% | $1,433,495↑32% | — |
| 2016 | $738,471↑10% | $619,800↓19% | $1,087,064↓11% | — |
| 2015 | $670,512↓13% | $761,883↓19% | $1,222,857↑3% | — |
| 2014 | $768,592↑8% | $938,930↑78% | $1,192,973↓2% | — |
| 2013 | $710,592↑22% | $527,175↓29% | $1,220,735↑20% | — |
| 2012 | $580,972↓2% | $742,847↑16% | $1,021,387↓13% | — |
| 2011 | $591,540 | $641,659 | $1,167,967 | — |
Frequently Asked Questions
What does Reflex Sympathetic Dystrophy Syndrome Association Rsdsa do?▼
Reflex Sympathetic Dystrophy Syndrome Association Rsdsa is a medical research nonprofit organization based in Connecticut. It is classified under NTEE code H52Z and is registered as a 501(c) tax-exempt organization with the IRS.
Is Reflex Sympathetic Dystrophy Syndrome Association Rsdsa financially healthy?▼
Financial health scoring requires Form 990 filing data. Check back as we process more filings for Reflex Sympathetic Dystrophy Syndrome Association Rsdsa.
How much revenue does Reflex Sympathetic Dystrophy Syndrome Association Rsdsa generate?▼
Reflex Sympathetic Dystrophy Syndrome Association Rsdsa reports $524K in annual revenue and holds $2.0M in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Medical Research category, or browse all nonprofits in Connecticut.